Accuhealth Technologies Inc is categorized under Commercial Medical Research in Atlanta, GA and active since 2012.
Accuhealth Technologies Inc was established in 2012, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Elizabeth Ofili at the company’s single location by writing to 5550 Claire Rose Lane, Atlanta, Georgia GA 30327 or by phoning (425) 429-8900. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Accuhealth Technologies Inc |
| Contact Person: | Elizabeth Ofili |
| Address: | 5550 Claire Rose Lane, Atlanta, Georgia 30327 |
| Phone Number: | (425) 429-8900 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Accuhealth Technologies Inc was started in 2012 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Elizabeth Ofili for inquiries that concern Accuhealth Technologies Inc by calling the company number (425) 429-8900, as your correspondence is most welcome. Additionally, the physical location of the single location of Accuhealth Technologies Inc can be found at the coordinates 33.906515,-84.403259 as well as the street address 5550 Claire Rose Lane in Atlanta, Georgia 30327.
For its online presence, you may visit Accuhealth Technologies Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.